Sight Sciences CEO sells shares for RSU taxes

Sight Sciences, Inc. President and CEO Paul Badawi reported an open-market sale of 28,684 shares of Common Stock at a weighted average price of $5.42 per share.

Rhea-AI Filing Summary

Sight Sciences, Inc. President and CEO Paul Badawi reported an open-market sale of 28,684 shares of Common Stock at a weighted average price of $5.42 per share. According to the filing, the shares were sold to cover his tax liability arising from the vesting of restricted stock units (RSUs).

After this tax-related sale, Badawi holds a total of 6,122,472 shares, consisting of 5,572,746 shares of Common Stock and 549,726 additional shares that will be issued upon future vesting and settlement of unvested RSUs. The transaction represents only a small portion of his overall equity position.

Insider Trade Summary 10b5-1

Net Seller: 28,684 shares

Net Sell 1 txn

Insider Badawi Paul

Role President and CEO

Sold 28,684 shs ($155K)

Type	Security	Shares	Price	Value
Sale	Common Stock	28,684	$5.42	$155K

Holdings After Transaction: Common Stock — 6,122,472 shares (Direct)

Footnotes (3)

1. F1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
2. F2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.24 to $5.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. Includes (i) 5,572,746 shares of Common Stock, and (ii) 549,726 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

Key Figures

Shares sold: 28,684 shares Weighted average sale price: $5.42 per share Post-transaction holdings: 6,122,472 shares +3 more

6 metrics

Shares sold 28,684 shares Open-market sale on 2026-07-01 to cover RSU taxes

Weighted average sale price $5.42 per share Common Stock sale range $5.24–$5.58

Post-transaction holdings 6,122,472 shares Total equity position following the reported sale

Common Stock held 5,572,746 shares Portion of holdings in currently owned Common Stock

Unvested RSU-linked shares 549,726 shares Shares to be issued upon future RSU vesting and settlement

Net share change -28,684 shares Net effect of this Form 4’s transactions

Key Terms

restricted stock units ("RSUs"), weighted average price, vesting and settlement

3 terms

restricted stock units ("RSUs") financial

"sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

weighted average price financial

"Reflects the weighted average price at which the shares of Common Stock were sold."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

vesting and settlement financial

"shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Sight Sciences (SGHT) CEO Paul Badawi report in this Form 4?

Sight Sciences CEO Paul Badawi reported selling 28,684 shares of Common Stock at a weighted average price of $5.42 per share. The filing states the sale was made specifically to cover his tax liability from recently vested restricted stock units.

Why did Sight Sciences (SGHT) CEO Paul Badawi sell 28,684 shares?

The sale of 28,684 Sight Sciences shares was made to cover Paul Badawi’s personal tax liability from the vesting of restricted stock units. This type of transaction is typically administrative, reflecting tax obligations tied to equity compensation rather than a discretionary portfolio decision.

What price range were the Sight Sciences (SGHT) shares sold at in this transaction?

The reported weighted average sale price was $5.42 per share, with individual trade prices ranging from $5.24 to $5.58. The filing notes the CEO can provide detailed breakdowns of shares sold at each specific price within this range upon request.

How many Sight Sciences (SGHT) shares does CEO Paul Badawi hold after this sale?

After the transaction, Paul Badawi holds 6,122,472 shares linked to Sight Sciences. This includes 5,572,746 shares of Common Stock already owned and 549,726 additional shares that are scheduled to be issued when currently unvested restricted stock units vest and settle in the future.

Does the Sight Sciences (SGHT) Form 4 involve any stock options or derivatives?

This Form 4 does not show any option exercises or other derivative transactions. It reports only a sale of Common Stock and notes additional future shares tied to unvested restricted stock units, with no remaining derivative positions listed in the derivative summary section.

Is the Sight Sciences (SGHT) CEO’s sale a routine tax-related transaction?

Yes. The footnotes state the 28,684 shares were sold solely to cover the CEO’s tax liability from RSU vesting. Such tax-related sales are common with equity compensation programs and generally reflect required tax payments rather than changes in long-term ownership intentions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 07:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Badawi Paul

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		S		28,684(1)	D	$5.42(2)	6,122,472(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").

2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.24 to $5.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Includes (i) 5,572,746 shares of Common Stock, and (ii) 549,726 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

	/s/Jeremy Hayden, Attorney-in-Fact for Paul Badawi	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)